Femasys (FEMY) Common Equity (2020 - 2026)
Femasys' (FEMY) quarterly Common Equity came in at $7.3 million in Q1 2026, up 265.09% YoY from $2.0 million in Q1 2025, and up 24.2% on a QoQ basis from $5.9 million in Q4 2025.
Femasys (FEMY) Common Equity (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Common Equity data on file, last reported at $7.3 million in Q1 2026.
- Quarterly Common Equity rose 265.09% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (up 265.09% YoY) and the FY2025 annual result came in at $5.9 million, up 154.7% from the prior year.
- Common Equity advanced to $7.3 million in Q1 2026, from $5.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $23.5 million in Q1 2022 to a low of $1.5 million in Q2 2025.
- A 5-year average of $11.1 million and a median of $11.3 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2024 — Common Equity plunged 87.44% — and 2026, when it jumped 265.09%.
- Tracing FEMY's Common Equity over 5 years: stood at $15.2 million in 2022, then advanced by 20.4% to $18.4 million in 2023, then sank by 87.44% to $2.3 million in 2024, then soared by 154.7% to $5.9 million in 2025, then climbed by 24.2% to $7.3 million in 2026.
- The last three Common Equity figures came in at $7.3 million (Q1 2026), $5.9 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.29 Mn |
| Dec 31, 2025 | 5.87 Mn |
| Sep 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 5.97 Mn |
| Jun 30, 2024 | 11.25 Mn |
| Mar 31, 2024 | 15.61 Mn |
| Dec 31, 2023 | 18.35 Mn |
| Sep 30, 2023 | 10.44 Mn |
| Jun 30, 2023 | 12.88 Mn |
| Mar 31, 2023 | 12.36 Mn |
| Dec 31, 2022 | 15.24 Mn |
| Sep 30, 2022 | 18.01 Mn |
| Jun 30, 2022 | 20.94 Mn |
| Mar 31, 2022 | 23.49 Mn |
| Dec 31, 2021 | 26.33 Mn |
| Sep 30, 2021 | 28.65 Mn |
| Jun 30, 2021 | 30.88 Mn |